A provision of the Indian Patents Act allows for a compulsory license to be awarded after three years of the grant of patent on drugs that are deemed to be too costly. Other patent rulings are imminent. A long-running case...
Keywords: cancer drug Glivec, Bayer's monopoly, German drug maker Bayer, Global drug makers
Read More